6 Aug 2026, 21:07 UTC6 viewsread 6 August 2026
Photo
Photo, posted without a caption
Channel
InvestBio News
@biopharm_T
On this record: Topic · Growth · Engagement · Posts · Cite this entry
991subscribers
+3 since we began measuring on 6 August 2026
Risers and fallers across the register · movement among entries of Under 1,000.
Register entry
| Telegram ID | -1001495112360 |
|---|---|
| Type | Channel |
| Username | @biopharm_T |
| Created | Between 1 April 2019 and 31 October 2021 — estimated from Telegram’s id allocation, not measured. How this range is calculated. |
| First recorded | 6 August 2026 |
| Last confirmed live | 3 October 2026 |
| Measurements held | 7 |
| Confirmed unchanged | 1 time, most recently 3 October 2026 |
| On Telegram | t.me/biopharm_T |
Topic
Crypto & trading — a classification, not a measurement. An on-box language model (Qwen3.6-35B-A3B-FP8, prompt version 1) read this channel’s own recent posts on 19 September 2026 and assigned it the closest of 31 fixed categories, at 59% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and why it has no browse page of its own yet.
Growth
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 3 Oct 2026, 00:01 | 991 | +1 |
| 9 Sept 2026, 18:40 | 990 | -2 |
| 30 Aug 2026, 20:17 | 992 | -2 |
| 23 Aug 2026, 10:16 | 994 | -1 |
| 14 Aug 2026, 23:48 | 995 | +7 |
| 7 Aug 2026, 21:17 | 988 | no change |
| 6 Aug 2026, 21:16 | 988 | first reading |
Engagement
20 posts held, back to 4 August 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.
Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 20 posts for this entry, the most recent from 6 August 2026. An engagement rate over an empty window would be a number about nothing.
Recent posts
6 Aug 2026, 21:07 UTC6 viewsread 6 August 2026
Photo
Photo, posted without a caption
6 Aug 2026, 21:07 UTC6 viewsread 6 August 2026
💊 Pipeline updates 〰〰〰〰〰〰〰〰〰〰〰 Company: $REPL - Replimune Group Inc. Drug: TUDRIQEV (vusolimogene oderparepvec-wtpg) and OPDIVO (nivolumab) - (IGNYTE-3) (Non-melanoma (NMSC) / Non-small cell lung cancer) Stage: Approved Catalyst: FDA accelerated approval granted on August 6, 2026. 〰〰〰〰〰〰〰〰〰〰〰 Company: $IOVA - Iovance Biotherapeutics Inc. Drug: LN-145 - (IOV-COM-202) (Non-small cell lung cancer) Stage: Phase 2…
6 Aug 2026, 21:07 UTC5 viewsread 6 August 2026
⬇ continuation ⬇ Sight Sciences, Inc. (NASDAQ: $SGHT) reported second-quarter revenue of $23.4 million, representing a robust 19.4% year-over-year increase and exceeding analyst projections; notably, the firm achieved a narrower-than-anticipated quarterly net loss of $0.08 per share. Management highlighted that exceptionally strong commercial momentum has driven top-line growth, while simultaneously reporting narrow…
6 Aug 2026, 21:07 UTC5 viewsread 6 August 2026
📰 Daily Biotech Stock Updates 〰〰〰〰〰〰〰〰〰〰〰〰 BioVie Inc. (NASDAQ: $BIVI) reported Phase 2 SUNRISE-PD data for bezisterim in early Parkinson’s met primary endpoints with statistically significant MDS-UPDRS improvements and biomarker reductions, including neurofilament light chain, but the readout may have been viewed cautiously given the small proof-of-concept design, reliance on inflammatory-enriched responders, and n…
6 Aug 2026, 13:07 UTC37 viewsread 6 August 2026
Photo
Photo, posted without a caption
6 Aug 2026, 13:07 UTC37 viewsread 6 August 2026
Photo
Photo, posted without a caption
6 Aug 2026, 13:07 UTC38 viewsread 6 August 2026
⬇ continuation ⬇ Mirum Pharmaceuticals, Inc. (NASDAQ: $MIRM) disclosed second-quarter net product revenue of $176.2 million, marking a 37.5% year-over-year increase and exceeding analyst projections; consequently, the company upwardly revised its 2026 revenue guidance to a range of $680 million to $700 million. However, shares faced downward pressure following FDA feedback that deferred the anticipated New Drug Appl…
6 Aug 2026, 13:07 UTC30 viewsread 6 August 2026
📰 Pre-Market Biotech Stock 〰〰〰〰〰〰〰〰〰〰〰〰 Insmed Incorporated (NASDAQ: $INSM) disclosed second-quarter revenue that surpassed analyst projections, propelled by the sustained commercial expansion of ARIKAYCE and Brinsupri; notably, the firm reported a narrower-than-anticipated quarterly net loss. Management emphasized the robust momentum across its respiratory portfolio and underscored consistent pipeline advancement, …
5 Aug 2026, 21:07 UTC46 viewsread 6 August 2026
Photo
Photo, posted without a caption
5 Aug 2026, 21:07 UTC45 viewsread 6 August 2026
Photo
Photo, posted without a caption
5 Aug 2026, 21:07 UTC45 viewsread 6 August 2026
💊 Pipeline updates 〰〰〰〰〰〰〰〰〰〰〰 Company: $EYPT - EyePoint Inc. Drug: DURAVYU (EYP-1901) - (LUGANO) (Wet age-related macular degeneration) Stage: Phase 2 Catalyst: Phase 3 trial dosing was initiated based on DAVIO-2 study results, noted October 24, 2024. Topline data 56-week expected in August 2026. 〰〰〰〰〰〰〰〰〰〰〰 Company: $ACRV - Acrivon Therapeutics Inc. Drug: ACR-2316 (Dual WEE1 and PKMYT1 inhibitor, Solid tumor…
Showing the 12 most recent of 20 posts we hold for @biopharm_T. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
Cite this entry
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 3 October 2026 — this entry's latest reading, not the date you are reading this.
“InvestBio News” (@biopharm_T), 991 subscribers as measured 3 October 2026. Telegram Register, tgregister.com/channel/biopharm_T.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.